For example, holoprosencephaly through altered Shh signalling can be observed with alkaloids that alter the post-translational modifications of the Shh protein; by agents that inhibit specialized enzymes in the cholesterol synthesis pathway consequently affecting the Shh modifications; or by mutations in genes encoding for those enzymes or the Shh protein itself. This evidence concerns the gene SHH and holoprosencephaly.